abstract |
Ophthalmic sustained release formulations, containing the active ingredients in the form of high viscosity solutions, formed from a mixture of water and polyoxyethylene-polyoxypropylene copolymers (poloxamers) having approximately 70% of polyoxyethylene units and an average molecular weight of approximately 12,500, characterized in that they contain, as stabilizers, nonionic surfactants. |